Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Macleod (London, United Kingdom), G. Donaldson (London, United Kingdom), J. Allinson (London, United Kingdom), D. Wiseman (London, United Kingdom), J. Wedzicha (London, United Kingdom). Relationship of cardiac biomarkers in COPD to exacerbation and hyperinflation. 151

Member's Comments

No comment yet.

Related content which might interest you: Role of lung hyperinflation on cardiac function during acute exacerbations of COPD Source: Virtual Congress 2020 – From respiratory physiology to diagnosis and treatment Year: 2020 Relationship between the severity of dyspnea and pulmonary function in acute COPD exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 251s Year: 2002 Relationship between changes in dynamic hyperinflation and cardiovascular parameters during exercise in patients with COPD Source: International Congress 2019 – Exploring exercise responses in respiratory diseases Year: 2019 Relationship of airway dimensions with airflow limitation or lung volumes in chronic obstructive pulmonary disease (COPD) Source: Eur Respir Rev 2006; 15: 197-199 Year: 2006 The importance of lung hyperinflation during exacerbations of COPD Source: ISSN=ISSN 1810-6838, ISBN=, page=356 Year: 2006 Cardiac biomarkers and outcomes of COPD exacerbations Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Relationship of airway dimensions with lung volumes in chronic obstrucive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 655s Year: 2006 Correlation of dyspnea and physiological impairment in COPD exacerbation Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Pulmonary biomarkers in asthma and COPD Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Bronchodilator-induced changes in dynamic hyperinflation but not in airway obstruction are associated with improvement in dyspnoea in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 174s Year: 2001 Lung hyperinflation in COPD: the impact of pharmacotherapy Source: Eur Respir Rev 2006; 15: 85-89 Year: 2006 Non-invasive ventilation and endothelial function in acute exacerbations of chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration Year: 2019 Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Pulmonary rehabilitation affects lung hyperinflation and cardiovascular response to exercise in COPD Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012 Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Relation of cardiac enzymes and echocardiographical findings with long-term mortality after chronic obstructive pulmonary disease exacerbation Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Dynamic hyperinflation contributes to systemic and airway inflammation in patients with COPD Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019 The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012 Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016